Outset Medical, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Outset Medical, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
  • Outset Medical, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 281 %, a 269% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 281 +205 +269% Sep 30, 2024
Q2 2024 194 +135 +232% Jun 30, 2024
Q1 2024 136 +90.7 +199% Mar 31, 2024
Q4 2023 95.5 +60.1 +169% Dec 31, 2023
Q3 2023 76.2 +49.1 +182% Sep 30, 2023
Q2 2023 58.2 +34.2 +142% Jun 30, 2023
Q1 2023 45.5 +24.5 +116% Mar 31, 2023
Q4 2022 35.5 +14.7 +71.1% Dec 31, 2022
Q3 2022 27 +6.64 +32.6% Sep 30, 2022
Q2 2022 24.1 +3.38 +16.3% Jun 30, 2022
Q1 2022 21 Mar 31, 2022
Q4 2021 20.7 Dec 31, 2021
Q3 2021 20.4 Sep 30, 2021
Q2 2021 20.7 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.